logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Matthias Stelljes

University Hospital
H指数:60
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP

ROCK2抑制剤belumosudil对慢性GVHD的疗效与安全性：来自belumosudil MAP大型德奥人群多中心回顾性分析的结果

Bone Marrow Transplantation
IF5.2
2026-10-050
PRE
Udo Holtick; Elisa Sala; Katharina Egger-Heidrich; Mareike Verbeek; Silke Heidenreich; Alexander Denk; Giuliano Filippini Velazquez; Christina Rautenberg; Helene Schmeller; Lasse Jost; Tim Richardson; Christof Scheid; Katrin Strauss; Franziska Taube; Katharina Nickel; Christoph Schmid; Sara Jennrich; Tobias A. W. Holderried; Friedrich Stölzel; Laurenz Steiner; Marius Dohse; Mohamad-Kamal Yaakoub; Normann Steiner; Olaf Penack; Darina Kodzhabasheva; Jochen J. Frietsch; Matthias Stelljes; Caroline Pabst; Ina Rudolph; Guido Kobbe; Claudia Wehr; Kristina Maas-Bauer; Robert Zeiser; Daniel Wolff; Matthias A. Fante
Gp120-Activated Allogeneic Regulatory T cells for Prevention of Graft-versus-Host-Disease – a First-in-Human Trial

Gp120激活的同种异基因调节性T细胞预防移植物抗宿主病——一项首次人体试验

Transplantation and Cellular Therapy
IF4.4
2026-08-310
OAAI
Andrea Tuettenberg; Leo Ruhnke; Janine Schlöder; Niklas Zimmer; Christoph Rücker; Daniela Wehler; Katharina Epp; Dietlinde Janson; Katrin Wetzko; Christian Reicherts; Martin Bornhäuser; Robert Zeiser; Matthias Stelljes; Ralf Georg Meyer; Martin Wermke; Eva Maria Wagner-Drouet; Helmut Jonuleit
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT

氟达拉滨联合曲奥舒凡或全身照射作为异基因造血干细胞移植前急性淋巴细胞白血病的预处理疗法。来自EBMT ALWP的回顾性配对分析

Bone Marrow Transplantation
IF5.2
2026-07-080
OA
Ryszard Swoboda; Myriam Labopin; Nicolaus Kröger; Matthias Stelljes; Thomas Schroeder; Peter Dreger; Gesine Bug; Andrew McDonald; Tülay Özçelik; Montserrat Rovira; Igor Wolfgang Blau; Desiree Kunadt; Régis Peffault de Latour; Werner Rabitsch; Matthias Eder; Marie Therese Rubio; Alexandros Spyridonidis; Zinaida Peric; Sebastian Giebel; Mohamad Mohty; Fabio Ciceri
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia

异基因移植后急性白血病患者无白血病生存的综合性预后模型

Bone Marrow Transplantation
IF5.2
2026-07-020
OA
Alexandros Spyridonidis; Allain Thibeault Ferhat; Jacques Emmanuel Galimard; Thomas Schroeder; Régis Peffault de Latour; Nicolaus Kröger; Didier Blaise; Matthias Stelljes; Matthias Eder; Tobias Gedde-Dahl; Igor Wolfgang Blau; Ibrahim Yakoub-Agha; Edouard Forcade; Anne Huynh; Francesca Kinsella; Hélène Labussière-Wallet; Jakob Passweg; Robert Zeiser; Mohamed Houhou; Bipin Savani; Roni Shouval; Jurjen Versluis; Mohamad Mohty; Fabio Ciceri; Annalisa Ruggeri
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT

非清髓性预处理与减低强度预处理在≥65岁急性髓系白血病患者异基因造血干细胞移植中的比较：EBMT ALWP的研究

Bone Marrow Transplantation
IF5.2
2026-06-210
PRE
A. Kanellopoulos; M. Labopin; A. Spyridonidis; E. Nikolousis; U. Platzbecker; D. Blaise; H. Sengeloev; F. Kinsella; T. Schroeder; G. Choi; E. Tholouli; P. Dreger; V. Potter; G. Socie; A. E. C. Broers; J. Passweg; M. Eder; G. Olesen; J. H. Bourhis; G. Van Gorkom; M. Stelljes; J. O. Bay; J. L. Byrne; P. Ceballos; J. A. Snowden; Bipin N. Savani; E. Brissot; F. Ciceri; A. Nagler; M. Mohty
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)

IPI风险因素对复发或难治性大B细胞淋巴瘤（LBCL）治疗中CAR T细胞疗法或同种异体干细胞移植的影响

Bone Marrow Transplantation
IF5.2
2026-06-190
PRE
Anna Ossami Saidy; Ariane Boumendil; Peter Dreger; Federico Stella; Ron Ram; Nicolaus Kröger; Luca Castagna; Thomas Pabst; Gerald G. Wulf; Alejandro Martin Garcia-Sancho; Carlos Solano; Matthias Stelljes; Hans C. Reinhardt; Edouard Forcade; Malte von Bonin; Inken Hilgendorf; Joaquin Martínez López; Wolfgang Bethge; Ali Bazarbachi; Anna Sureda; Norbert Schmitz; Bertram Glass
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis

嵌合抗原受体T细胞疗法在老年（≥70岁）和年轻多发性骨髓瘤患者中疗效相当且安全性一致：一项多中心回顾性分析

Blood Cancer Journal
IF11.6
2026-06-020
OAAI
Philipp Berning; Markus Maulhardt; Hristo Boyadzhiev; Anca-Maria Albici; Snjezana Janjetovic; Anna Ossami Saidy; Christian Schultze-Florey; Simon Call; Friedrich Stölzel; Annamaria Brioli; Michael Daskalakis; Juliane Knust; Justin Hasenkamp; Rebecca Wurm-Kuczera; Alexander Pohlmann; Matthias Stelljes; Cyrus Khandanpour; Ulrike Bacher; Amelie Boquoi; Florian H. Heidel; Hans Christian Reinhardt; Gerald Wulf; Natalie Schub; Bastian von Tresckow; Georg Lenz; Thomas Pabst; Evgenii Shumilov
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patients

德国年轻成人急性白血病自体造血干细胞移植后的生存趋势：与更年轻和更年长患者的比较

Transplantation and Cellular Therapy
IF4.4
2026-04-120
PREAI
Jochen J Frietsch; Sarah Flossdorf; Ashrafossadat Ahmadian; Rita Beier; Claudia Schuh; Thomas Schroeder; Igor-Wolfgang Blau; Matthias Stelljes; Nicolaus Kröger; Katharina Egger-Heidrich; Matthias Eder; Peter Dreger; Johanna Tischer; Eva Wagner-Drouet; Peter Bader; Martin G Sauer; Barbara Meissner; Katharina Fleischhauer; Inken Hilgendorf
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies

单倍型相合移植联合移植后环磷酰胺不劣于9/10相合无关供者移植联合抗胸腺细胞球蛋白在髓系恶性肿瘤患者中的应用

Bone Marrow Transplantation
IF5.2
2026-04-080
OAAI
Andrea Gantner; Svenja Labuhn; Daniel Fürst; Sophie Mannes; Sarah Flossdorf; Francis Ayuketang Ayuk; Thomas Schroeder; Matthias Stelljes; Robert Zeiser; Peter Dreger; Matthias Eder; Igor Wolfgang Blau; Johannes Schetelig; Arne Brecht; Andreas Burchert; Matthias Edinger; Verena Wais; Hubert Schrezenmeier; Hartmut Döhner; Sandra Schmeller; Katharina Fleischhauer; Nicolaus Kröger; Elisa Sala
Real-world experience withTabelecleucel within and beyond the approval label

Tabelecleucel在标签内和标签外的真实世界经验

Blood Advances
IF7.1
2026-03-280
OAAI
Kiavasch Mohammad Nejad Farid; Florian Kocher; Tobias Arnold; Josia Fauser; Elisa Henze; Christian Schultze-Florey; Carmen Diana Herling; Vladan Vučinić; Christian Reicherts; Matthias Stelljes; Raphael Stadelmann; Christof Scheid; Udo Holtick; Stavroula Masouridi-Levrat; Marc Wehrli; Urban Novak; Paul Schnitzler; Chiraz Ben-Salah; Isabelle Krämer; Anita Schmitt
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

DNMT3A基因突变对接受首次缓解期异基因移植的AML患者生存的影响，取决于核型及共现突变。

Bone Marrow Transplantation
IF5.2
2025-12-230
PRE
Iman Abou Dalle; Jacques-Emmanuel Galimard; Xavier Poire; Jaime Sanz; Anne Huynh; Nicolaus Kröger; Eva Maria Wagner-Drouet; David Burns; Matthias Eder; Bruno Lioure; Depei Wu; Jiri Mayer; Kristina Carlson; Matthias Stelljes; Matthew Collin; Mahmoud Aljurf; Arnon Nagler; Jordi Esteve; Fabio Ciceri; Ali Bazarbachi; Mohamad Mohty
Pretransplant HMA and Venetoclax in AML patients – a Real-World Analysis from the Cooperative Transplant Study Group

移植前HMA和Venetoclax在AML患者中的应用——来自合作移植研究组的真实世界分析

Transplantation and Cellular Therapy
IF4.4
2025-12-150
OAAI
Christina Rautenberg; Matthias Stelljes; Gesine Bug; Udo Holtick; Edgar Jost; Sara Jennrich; Annemarie Mohring; Johanna Tischer; Alessia Fraccaroli; Christoph Schliemann; Laura K. Schmalbrock; Lars Bullinger; Judith Metzdorf; Krischan Braitsch; Mareike Verbeek; Katharina Götze; Fabian Acker; H. Christian Reinhardt; Nicolaus Kröger; Thomas Schroeder
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial

阿扎胞苷治疗具有可测量残留病灶的患者中的骨髓增生异常综合征/急性髓系白血病：RELAZA2试验的最终长期结果

Blood
IF23.1
2025-12-100
PRE
Anne Sophie Platzbecker; Julia-Annabell Georgi; Jan Moritz Middeke; Katja Sockel; Rebekka Wehner; Regina Herbst; Dominik Wolf; Claudia D. Baldus; Uta Oelschlägel; Anke Mütherig; Lars Fransecky; Richard Noppeney; Gesine Bug; Katharina S. Götze; Alwin Krämer; Tilmann Bochtler; Matthias Stelljes; Eva Eßeling; Friedrich Stölzel; Malte von Bonin
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary

接受伊诺妥珠单抗治疗并在干细胞移植前的急性淋巴细胞白血病患者结局：简易语言摘要

Future Oncology
IF2.6
2025-12-070
OAAI
Marcos de Lima; Partow Kebriaei; Francesco Lanza; Christina Cho; Gizelle Popradi; Manmeet Kaur; Mei-Jie Zhang; Fan Zhang; Richa Shah; Erik Vandendries; Kofi Asomaning; Stephanie Dorman; Matthias Stelljes; David I. Marks; Wael Saber
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia

减低强度预处理联合8 Gy全身照射在成人急性淋巴细胞白血病患者中的应用

Bone Marrow Transplantation
IF5.2
2025-12-060
OAAI
Klaus Wethmar; Matthias Edinger; Kerstin Schäfer-Eckart; Matthias Stelljes; Thomas Schroeder; Kristina Sohlbach; Renate Arnold; Michael Stadler; Gesine Bug; Martin Bornhäuser; Gerald Wulf; Wolfgang Bethge; Edgar Jost; Daniel Teschner; Guido Kobbe; Monika Brüggemann; Lena Reiser; Dieter Hoelzer; Nicola Gökbuget; Stefan Schönland
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

移植后环磷酰胺与抗胸腺细胞球蛋白在合并心血管并发症、接受无关供者异基因造血细胞移植治疗首次完全缓解期急性髓系白血病患者中的比较：一项来自EBMT ALWP的回顾性配对分析

Bone Marrow Transplantation
IF5.2
2025-12-030
OAAI
Jan Vydra; Allain-Thibeault Ferhat; Nicolaus Kröger; Tobias Gedde-Dahl; Matthias Eder; Thomas Schroeder; Urpu Salmenniemi; Régis Peffault de Latour; Jakob Passweg; Ibrahim Yakoub-Agha; Alessandro Rambaldi; Robert Zeiser; Matthias Stelljes; Kristina Carlson; Cristina Castilla-Llorente; Alexandros Spyridonidis; Bipin Savani; Fabio Ciceri; Mohamad Mohty
Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemia

异基因造血干细胞移植后活动性急性髓系白血病患者的复发

Leukemia Research
IF2.2
2025-12-010
OAAI
Ronnacker, Julian; Urbahn, Marc-Andre; Reicherts, Christian; Kolloch, Lina; Berning, Philipp; Berdel, Andrew F.; Call, Simon; Floeth, Matthias; Marx, Julia; Esseling, Eva; Mikesch, Jan-Henrik; Schliemann, Christoph; Eich, Hans Theodor; Lenz, Georg; Stelljes, Matthias
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party

供者选择对不良风险AML接受造血细胞移植的影响：EBMT急性白血病工作组的研究

Bone Marrow Transplantation
IF5.2
2025-11-290
PRE
Marta Villalba; Allain-Thibeault Ferhat; Tobias Gedde-Dahl; Gerard Socie; Anne Huynh; Igor Wolfgang Blau; Ibrahim Yakoub-Agha; Didier Blaise; Matthias Eder; Edouard Forcade; Renato Fanin; Jakob Passweg; Charles Crawley; Matthias Stelljes; Friedrich Stölzel; Nicolaus Kroeger; Henrik Sengeloev; Patrice Ceballos; Helene Labussiere-Wallet; Xavier Poiré; Jordi Esteve; Bipin Savani; Arnon Nagler; Simona Piemontese; Jaime Sanz; Mohamad Mohty; Fabio Ciceri
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT

异基因造血干细胞移植不同供者类型在初治难治性急性髓系白血病中的疗效：EBMT ALWP 报告

Bone Marrow Transplantation
IF5.2
2025-11-210
PRE
Kordelia Barbullushi; Myriam Labopin; Nicolaus Kröger; Jürgen Finke; Matthias Stelljes; Arnold Ganser; Wolfgang Bethge; Hermann Einsele; Johannes Schetelig; Renato Fanin; Pavel Jindra; Thomas Schroeder; Jochen Casper; Matthias Edinger; Jakob Passweg; Edouard Forcade; Johanna Tischer; Arnon Nagler; Fabio Ciceri; Mohamad Mohty

研究方向

暂未获取到该数据
N
Nicolaus Kröger
H 指数:101论文数:1,317被引数:4.4万
W
Wolfgang E. Berdel
H 指数:98论文数:993被引数:3.8万
M
Mohamad Mohty
H 指数:126论文数:2,144被引数:6.3万
G
Georg Lenz
H 指数:64论文数:622被引数:2.3万
C
Christoph Schliemann
H 指数:45论文数:310被引数:6,091
P
Peter Dreger
H 指数:82论文数:874被引数:2.4万
W
Wolfgang Bethge
H 指数:55论文数:480被引数:1.2万
J
Jürgen Finke
H 指数:87论文数:889被引数:3.0万
A
Arnon Nagler
H 指数:124论文数:2,110被引数:7.1万
F
Fabio Ciceri
H 指数:116论文数:1,423被引数:5.7万